Developer docs
API playgroundTry for free, no card

Search company profiles

Medical Engineering Institute

Full company profile

uuid002bzqk

Namestring
Medical Engineering Institute
Legal namestring
株式会社医用工学研究所
Websiteurl
meiz.co.jp
Company typeenum
Private
Founded yearint
2004
Descriptiontext

Medical Engineering Institute (株式会社医用工学研究所) is a Japanese healthcare data company founded in 2004 as a Mie University spinoff and headquartered in Tsu, Mie Prefecture. The company develops and operates CLISTA!, a medical data warehouse (DWH) that aggregates data from hospital electronic medical records, medical accounting systems, and departmental systems, deployed at 166 healthcare facilities in Japan including 43 university hospitals, 59 public hospitals, 29 quasi-public hospitals, and 35 private hospitals. Named customers include Asahikawa Medical University Hospital, Kurume University Hospital, National Hospital Organization Kyoto Medical Center, Toyohashi Municipal Hospital, Maebashi Red Cross Hospital, Keiyu Hospital, and Tokyo Saiseikai Central Hospital.

The product portfolio comprises three core lines: (1) CLISTA! and its modules (Search, Statistics, Push notifications, CLISTA!+) licensed to hospitals on subscription contracts with multi-year implementation cycles of approximately 6–9 months; (2) MEI RWD, a real-world data service providing anonymized/pseudonymized EMR-derived data from over 60 medical institutions covering approximately 6 million patient records as of June 2026 (targeting ~10 million by end of FY2026) to pharmaceutical and academic customers including Rohto Pharmaceutical and Takeda Pharmaceutical; and (3) Two-In (ツーイン), a patient-facing PHR mobile app launched in July 2025 and distributed through partner hospitals on a B2B2C basis. Revenue mix spans subscription licensing, data monetization, professional services, and a freemium patient app.

The company became a consolidated subsidiary of KDDI Corporation in April 2025 following an additional investment that increased registered capital from 90 million yen to 1,085 million yen. Through the KDDI partnership, MEI accesses the Osaka Sakai AI Data Center with NVIDIA GB200 NVL72 GPU infrastructure, sovereign cloud, ELYZA LLM technology, and ARISE analytics capabilities. The company holds ISO 27001 (ISMS) certification since 2015 and operates within Japan's APPI, GDPR, and CCPA compliance frameworks for medical data handling.

Short descriptiontext

Medical Engineering Institute provides CLISTA! medical data warehouse systems, real-world data services, and the Two-In patient app to Japanese hospitals and pharmaceutical companies, with 166 facilities deployed and 6 million patient records as of June 2026.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersTsu, Japan
HQ citystring
Tsu
HQ countrystring
Japan
HQ regionstring
Asia
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical data warehouse, real-world data services, hospital management analytics, electronic medical records integration, clinical pathway analysis
Industry4 codes
1Real-World Data (RWD) Platforms & Clinical Data Curation
CodeHLACAIAJPrimaryYes
2FHIR/HL7 Data Repositories & Canonical Data Models
CodeHLACAIAIPrimaryNo
3Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms
CodeHLACAOAMPrimaryNo
4Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D)
CodeHLAGAJAFPrimaryNo
NAICS code2 codes
  • Custom Computer Programming Services541511
  • Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services518
SIC code2 codes
  • Services-Computer Programming, Data Processing, Etc.7370
  • Services-Health Services8000
Product category
Healthcare Data Analytics Software
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1CLISTA! Medical DWH System
TypeSubscription Recurring
Description

Licensing and deployment of the CLISTA! medical data warehouse system to hospitals. The company provides system installation, integration with hospital EMR and departmental systems, and ongoing support. Includes search, statistics, push notification, and CLISTA!+ modules.

meiz.co.jp
2Real-World Data (RWD) Services
TypeData Monetisation
Description

Provision of anonymized/pseudonymized electronic medical record data to pharmaceutical companies and academic institutions for clinical research, drug development, market analysis, and evidence generation. Services include analysis reports, database provision, and research support.

meiz.co.jp
3ツーイン (Two-In) Patient App
TypeFreemium
Description

Free PHR application for patients provided free of charge to users. Revenue model appears to be B2B, with hospitals (as medical institutions) deploying the service for their patients.

meiz.co.jp
4Hospital Management Consulting / Support Services
TypeProfessional Services
Description

Professional services including hospital cost accounting system (HOMAS-Cloud), reporting outsourcing services, and implementation/coordinating services for medical data platform deployment.

meiz.co.jp
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
Pricing details2 tiers
1CLISTA! licensing is offered with concurrent access licenses and per-client licenses
ModelSubscriptionBilling cadenceAnnual
Notes

License types include concurrent access license and client-based license. Pricing not publicly disclosed — inquiries handled via contact form.

meiz.co.jp
2Implementation and consulting services priced separately
ModelHybridBilling cadenceMulti-year contract
Notes

System implementation takes approximately 6-9 months. License additions and departmental system connections available post-deployment at additional cost.

meiz.co.jp
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 5 records shown
1CLISTA!
Description

Medical data warehouse (DWH) system for hospitals that aggregates data from electronic medical records, medical accounting systems, and departmental systems for search, statistics, analysis, and alert notifications.

meiz.co.jp
+4 more records
Core offering1 text field

Medical Engineering Institute develops and sells the CLISTA! medical data warehouse (DWH) system that aggregates data from hospital electronic medical records, medical accounting, and departmental systems for search, statistical analysis, and alert notifications. It also provides MEI RWD (Real-World Data) services that supply anonymized/pseudonymized electronic medical record data to pharmaceutical companies and academic institutions, and operates the Two-In patient-facing mobile application (PHR) that connects patients with their medical institutions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Alert notification unread period reduced from average 55 days to 2.86 days at Asahikawa Medical University Hospital
+3 more records
Product overview1 text field

Medical Engineering Institute offers a unified medical data platform portfolio comprising CLISTA! as the core healthcare DWH system, RWD (Real-World Data) services for pharmaceutical and research applications, and the ツーイン patient-facing mobile app. CLISTA! serves as the foundational hospital data warehouse with modular add-ons including search functionality, statistical analysis, push notifications, and CLISTA!+ for internal data sharing. The RWD service leverages the CLISTA! infrastructure to provide anonymized/pseudonymized medical data to pharmaceutical companies and academic researchers. The ツーイン app connects to hospital systems to deliver patient-facing services including appointment management and health record access.

Product and service4 records
1CLISTA! (クリスタ)
CategoryHealthcare Data Warehouse Software
Description

Healthcare data warehouse (DWH) system that aggregates and integrates data from hospital electronic medical records, medical accounting systems, and various departmental systems (radiology, pathology, nursing, etc.). Enables cross-system search, statistical analysis, push-notification alerts, and data visualization for hospital management, clinical operations, medical safety, and research support. Installed at 166 facilities as of 2026 including 43 university hospitals, 59 public hospitals, 29 quasi-public hospitals, and 35 private hospitals.

2MEI RWD (Real-World Data Service)
CategoryReal-World Data Analytics Services
Description

Real-World Data service providing anonymized/pseudonymized electronic medical record data and analysis services from over 60 partner medical institutions (80+ as of mid-2026) to pharmaceutical companies and academia for drug efficacy verification, post-marketing surveillance, clinical evidence generation, HEOR/HTA, medical affairs, and clinical research. Data covers examination results, prescriptions, procedures, and outcomes in chronological order, available approximately 1 month after clinical encounters.

3Two-In (ツーイン) Patient App
CategoryPatient Engagement Mobile Application
Description

Patient-facing mobile PHR application enabling patients to check appointments, view waiting numbers, receive notifications, access test results, record health metrics (blood pressure, blood glucose, weight, steps, sleep), and share information with family members and medical institutions. Provided free to end users; hospitals pay for deployment and integration.

4HOMAS-Cloud Hospital Cost Accounting System
CategoryHospital Cost Accounting Software
Description

Hospital cost accounting system offered by Medical Engineering Institute as part of its hospital management support services, deployed alongside CLISTA! to enable cost-side analysis for hospital management.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-04-01
Description

Joint project with KDDI and MEI using the KDDI Osaka Sakai AI Data Center to perform AI-powered multi-angle analysis of medical big data. Starting April 2026, the three companies will conduct exploratory projects for new patient value creation, with Takeda focusing on drug discovery and clinical research applications.

2東京都済生会中央病院 (Tokyo Saiseikai Central Hospital)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-18
Description

Collaborative clinical pathway analysis using CLISTA! since 2024. Two-phase program: Phase 1 (2024) — digitalization of pathway visualization; Phase 2 (2025) — scoring methodology for quantitative pathway quality assessment. Joint academic presentation at Japan Clinical Pathway Society.

meiz.co.jp
3戦略的イノベーション創造プログラム (SIP)
Strategic tierMajorTypeOthersAnnounced on2025-10-01
Description

MEI data adopted for the SIP 'Integrated Healthcare System' program's generative AI utilization project, a national-level government initiative in Japan for healthcare innovation.

meiz.co.jp
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-09-25
Description

KDDI's AI Data Center uses NVIDIA GB200 NVL72 GPU infrastructure for medical big data processing. MEI leverages this infrastructure through KDDI partnership for AI-powered medical data analysis and medical-specialized LLM development.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-09-25
Description

Collaboration through KDDI partnership for Google Cloud and Gemini AI technologies integrated into the medical vertical AI service architecture. Part of the 'medical vertical integrated AI service' concept combining medical big data, AI infrastructure, and generative AI.

Strategic tierMajorTypeTechnology or IntegrationAnnounced on2025-09-25
Description

ELYZA (KDDI group company) provides LLM technology for medical data analysis. Collaboration within KDDI group synergies to strengthen medical big data analytical capabilities through natural language processing and generative AI expertise.

Strategic tierMajorTypeTechnology or IntegrationAnnounced on2025-09-25
Description

KDDI group data science company with 350+ data scientists. Collaborates with MEI on advanced data analytics for medical applications. Part of KDDI group synergy strategy for medical data platform development.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-07-10
Description

First hospital to deploy Two-In patient app (July 2025). Joint project to improve patient experience and reduce staff workload. Hospital provides patient-facing deployment while MEI develops and operates the platform.

9ロート製薬株式会社 (Rohto Pharmaceutical Co., Ltd.)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-04-03
Description

MEI provided real-world data analysis for Rohto's renal disease treatment research, helping visualize and analyze treatment realities. The analysis yielded valuable insights suggesting new drugs could address current treatment challenges, supporting Rohto's drug development pipeline.

meiz.co.jp
Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Large-scale EHR and clinical data warehouse vendor. Provides similar hospital data aggregation and analytics capabilities as a much larger, internationally deployed incumbent, comparable to CLISTA! at enterprise scale.

TypeDirect peer
Description

Japanese healthcare platform operating MR-kun, MD-Voice, and drug marketing data businesses overlapping with MEI's pharma RWD and physician engagement services; targets overlapping pharmaceutical and hospital customers.

TypeDirect peer
Description

Japan's leading RWD/healthcare data analytics company for pharma and academia. Provides claims data and EMR-derived datasets; competes head-to-head with MEI RWD for pharmaceutical R&D, HEOR, and academic research contracts.

TypeDirect peer
Description

Roche-owned oncology-focused real-world evidence and EHR data platform. Highly comparable for hospital-derived EMR data monetization to pharma research customers, narrower therapeutic focus.

TypeBroad incumbent
Description

Global RWD/RWE and clinical research leader with broad pharma services portfolio. Operates significant Japan presence; competes with MEI RWD for pharma real-world evidence and observational research engagements.

TypeDirect peer
Description

Global real-world data network for clinical research and observational studies; comparable RWD-as-a-service model targeting pharma and academic users analogous to MEI RWD.

TypeBroad incumbent
Description

Healthcare data and coding analytics vendor with hospital analytics and documentation products, comparable in addressing hospital-level data analytics and reporting for clinical and administrative use.

TypeBroad incumbent
Description

Dominant US EHR/clinical data platform. Comparable in providing aggregated hospital data infrastructure with research and analytics modules; broader scale but limited Japan footprint.

TypeBroad incumbent
Description

Clinical research data platform provider for pharma. Comparable as a pharma-research oriented data infrastructure vendor competing for similar sponsor budgets on the R&D side.

TypeRegional player
Description

Japanese internet conglomerate with healthcare and consumer health data businesses. Operates in the same Japanese market with overlapping patient-facing health information and data analytics themes.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Medical Engineering Institute

Healthcare Data Analytics Softwaremeiz.co.jp

Medical Engineering Institute provides CLISTA! medical data warehouse systems, real-world data services, and the Two-In patient app to Japanese hospitals and pharmaceutical companies, with 166 facilities deployed and 6 million patient records as of June 2026.

What Medical Engineering Institute does

Medical Engineering Institute (株式会社医用工学研究所) is a Japanese healthcare data company founded in 2004 as a Mie University spinoff and headquartered in Tsu, Mie Prefecture. The company develops and operates CLISTA!, a medical data warehouse (DWH) that aggregates data from hospital electronic medical records, medical accounting systems, and departmental systems, deployed at 166 healthcare facilities in Japan including 43 university hospitals, 59 public hospitals, 29 quasi-public hospitals, and 35 private hospitals. Named customers include Asahikawa Medical University Hospital, Kurume University Hospital, National Hospital Organization Kyoto Medical Center, Toyohashi Municipal Hospital, Maebashi Red Cross Hospital, Keiyu Hospital, and Tokyo Saiseikai Central Hospital.

The product portfolio comprises three core lines: (1) CLISTA! and its modules (Search, Statistics, Push notifications, CLISTA!+) licensed to hospitals on subscription contracts with multi-year implementation cycles of approximately 6–9 months; (2) MEI RWD, a real-world data service providing anonymized/pseudonymized EMR-derived data from over 60 medical institutions covering approximately 6 million patient records as of June 2026 (targeting ~10 million by end of FY2026) to pharmaceutical and academic customers including Rohto Pharmaceutical and Takeda Pharmaceutical; and (3) Two-In (ツーイン), a patient-facing PHR mobile app launched in July 2025 and distributed through partner hospitals on a B2B2C basis. Revenue mix spans subscription licensing, data monetization, professional services, and a freemium patient app.

The company became a consolidated subsidiary of KDDI Corporation in April 2025 following an additional investment that increased registered capital from 90 million yen to 1,085 million yen. Through the KDDI partnership, MEI accesses the Osaka Sakai AI Data Center with NVIDIA GB200 NVL72 GPU infrastructure, sovereign cloud, ELYZA LLM technology, and ARISE analytics capabilities. The company holds ISO 27001 (ISMS) certification since 2015 and operates within Japan's APPI, GDPR, and CCPA compliance frameworks for medical data handling.

Medical Engineering Institute firmographics

Firmographics
Name
Medical Engineering Institute
Legal name
株式会社医用工学研究所
Website
https://meiz.co.jp
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
51–100 employees
Short description
Medical Engineering Institute provides CLISTA! medical data warehouse systems, real-world data services, and the Two-In patient app to Japanese hospitals and pharmaceutical companies, with 166 facilities deployed and 6 million patient records as of June 2026.
Ownership category
akta.pro rank

Medical Engineering Institute industry classification

Industry
Product category
Healthcare Data Analytics Software
NAICS
Custom Computer Programming Services (541511), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518)
SIC
Services-Computer Programming, Data Processing, Etc. (7370), Services-Health Services (8000)
akta.pro primary industry
Real-World Data (RWD) Platforms & Clinical Data Curation (HLACAIAJ)
akta.pro secondary industries
FHIR/HL7 Data Repositories & Canonical Data Models (HLACAIAI), Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms (HLACAOAM), Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D) (HLAGAJAF)

Keywords

  • Medical data warehouse
  • Real-world data services
  • Hospital management analytics
  • Electronic medical records integration
  • Clinical pathway analysis

Where Medical Engineering Institute is headquartered

Location

Headquarters

HQ city
Tsu
HQ country
Japan
HQ region
Asia

Offices5 records

Markets served

Medical Engineering Institute business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. CLISTA! Medical DWH System: Licensing and deployment of the CLISTA! medical data warehouse system to hospitals. The company provides system installation, integration with hospital EMR and departmental systems, and ongoing support. Includes search, statistics, push notification, and CLISTA!+ modules.
  2. Real-World Data (RWD) Services: Provision of anonymized/pseudonymized electronic medical record data to pharmaceutical companies and academic institutions for clinical research, drug development, market analysis, and evidence generation. Services include analysis reports, database provision, and research support.
  3. ツーイン (Two-In) Patient App: Free PHR application for patients provided free of charge to users. Revenue model appears to be B2B, with hospitals (as medical institutions) deploying the service for their patients.
  4. Hospital Management Consulting / Support Services: Professional services including hospital cost accounting system (HOMAS-Cloud), reporting outsourcing services, and implementation/coordinating services for medical data platform deployment.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualCLISTA! licensing is offered with concurrent access licenses and per-client licenses
HybridMulti-year contractImplementation and consulting services priced separately

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Medical Engineering Institute product offering

Product offering

Core offering

Medical Engineering Institute develops and sells the CLISTA! medical data warehouse (DWH) system that aggregates data from hospital electronic medical records, medical accounting, and departmental systems for search, statistical analysis, and alert notifications. It also provides MEI RWD (Real-World Data) services that supply anonymized/pseudonymized electronic medical record data to pharmaceutical companies and academic institutions, and operates the Two-In patient-facing mobile application (PHR) that connects patients with their medical institutions.

Product overview

Medical Engineering Institute offers a unified medical data platform portfolio comprising CLISTA! as the core healthcare DWH system, RWD (Real-World Data) services for pharmaceutical and research applications, and the ツーイン patient-facing mobile app. CLISTA! serves as the foundational hospital data warehouse with modular add-ons including search functionality, statistical analysis, push notifications, and CLISTA!+ for internal data sharing. The RWD service leverages the CLISTA! infrastructure to provide anonymized/pseudonymized medical data to pharmaceutical companies and academic researchers. The ツーイン app connects to hospital systems to deliver patient-facing services including appointment management and health record access.

Differentiator

Problem solved

Functional benefit

Brands

  • CLISTA!: Medical data warehouse (DWH) system for hospitals that aggregates data from electronic medical records, medical accounting systems, and departmental systems for search, statistics, analysis, and alert notifications.
  • ツーイン (Two-in)
  • MEI RWD
  • CLISTA!+
  • CLISTA! Push Function

Products and services

  • CLISTA! (クリスタ) Healthcare data warehouse (DWH) system that aggregates and integrates data from hospital electronic medical records, medical accounting systems, and various departmental systems (radiology, pathology, nursing, etc.). Enables cross-system search, statistical analysis, push-notification alerts, and data visualization for hospital management, clinical operations, medical safety, and research support. Installed at 166 facilities as of 2026 including 43 university hospitals, 59 public hospitals, 29 quasi-public hospitals, and 35 private hospitals.
  • MEI RWD (Real-World Data Service) Real-World Data service providing anonymized/pseudonymized electronic medical record data and analysis services from over 60 partner medical institutions (80+ as of mid-2026) to pharmaceutical companies and academia for drug efficacy verification, post-marketing surveillance, clinical evidence generation, HEOR/HTA, medical affairs, and clinical research. Data covers examination results, prescriptions, procedures, and outcomes in chronological order, available approximately 1 month after clinical encounters.
  • Two-In (ツーイン) Patient App Patient-facing mobile PHR application enabling patients to check appointments, view waiting numbers, receive notifications, access test results, record health metrics (blood pressure, blood glucose, weight, steps, sleep), and share information with family members and medical institutions. Provided free to end users; hospitals pay for deployment and integration.
  • HOMAS-Cloud Hospital Cost Accounting System Hospital cost accounting system offered by Medical Engineering Institute as part of its hospital management support services, deployed alongside CLISTA! to enable cost-side analysis for hospital management.

Quantifiable outcome

  • Alert notification unread period reduced from average 55 days to 2.86 days at Asahikawa Medical University Hospital
  • +3 more outcomes

Companies that use Medical Engineering Institute

Customer profile

Named customers9 records

Segments4 records

Ideal customer profiles2 records

Medical Engineering Institute technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

Feature6 records

Medical Engineering Institute partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered flagship, core and major.

  • 武田薬品工業株式会社 (Takeda Pharmaceutical Company Limited)flagshipStrategic or Co-development Partner · 1 April 2026Joint project with KDDI and MEI using the KDDI Osaka Sakai AI Data Center to perform AI-powered multi-angle analysis of medical big data. Starting April 2026, the three companies will conduct exploratory projects for new patient value creation, with Takeda focusing on drug discovery and clinical research applications.
  • 東京都済生会中央病院 (Tokyo Saiseikai Central Hospital)coreStrategic or Co-development Partner · 18 October 2025Collaborative clinical pathway analysis using CLISTA! since 2024. Two-phase program: Phase 1 (2024) — digitalization of pathway visualization; Phase 2 (2025) — scoring methodology for quantitative pathway quality assessment. Joint academic presentation at Japan Clinical Pathway Society.
  • 戦略的イノベーション創造プログラム (SIP)majorOthers · 1 October 2025MEI data adopted for the SIP 'Integrated Healthcare System' program's generative AI utilization project, a national-level government initiative in Japan for healthcare innovation.
  • NVIDIA CorporationcoreTechnology or Integration · 25 September 2025KDDI's AI Data Center uses NVIDIA GB200 NVL72 GPU infrastructure for medical big data processing. MEI leverages this infrastructure through KDDI partnership for AI-powered medical data analysis and medical-specialized LLM development.
  • Google LLC (Google Cloud/Gemini)coreTechnology or Integration · 25 September 2025Collaboration through KDDI partnership for Google Cloud and Gemini AI technologies integrated into the medical vertical AI service architecture. Part of the 'medical vertical integrated AI service' concept combining medical big data, AI infrastructure, and generative AI.
  • ELYZA Inc.majorTechnology or Integration · 25 September 2025ELYZA (KDDI group company) provides LLM technology for medical data analysis. Collaboration within KDDI group synergies to strengthen medical big data analytical capabilities through natural language processing and generative AI expertise.
  • ARISE analytics (KDDI Group)majorTechnology or Integration · 25 September 2025KDDI group data science company with 350+ data scientists. Collaborates with MEI on advanced data analytics for medical applications. Part of KDDI group synergy strategy for medical data platform development.
  • 前橋赤十字病院 (Maebashi Red Cross Hospital)flagshipStrategic or Co-development Partner · 10 July 2025First hospital to deploy Two-In patient app (July 2025). Joint project to improve patient experience and reduce staff workload. Hospital provides patient-facing deployment while MEI develops and operates the platform.
  • ロート製薬株式会社 (Rohto Pharmaceutical Co., Ltd.)coreStrategic or Co-development Partner · 3 April 2025MEI provided real-world data analysis for Rohto's renal disease treatment research, helping visualize and analyze treatment realities. The analysis yielded valuable insights suggesting new drugs could address current treatment challenges, supporting Rohto's drug development pipeline.

Scale indicators7 records

Recent moves8 records

Expansion highlights6 records

Medical Engineering Institute competitors and assessment

Company assessment

Broad incumbents

  • Oracle Health (formerly Cerner): Large-scale EHR and clinical data warehouse vendor. Provides similar hospital data aggregation and analytics capabilities as a much larger, internationally deployed incumbent, comparable to CLISTA! at enterprise scale.
  • IQVIA Holdings: Global RWD/RWE and clinical research leader with broad pharma services portfolio. Operates significant Japan presence; competes with MEI RWD for pharma real-world evidence and observational research engagements.
  • 3M Health Information Systems: Healthcare data and coding analytics vendor with hospital analytics and documentation products, comparable in addressing hospital-level data analytics and reporting for clinical and administrative use.
  • Epic Systems: Dominant US EHR/clinical data platform. Comparable in providing aggregated hospital data infrastructure with research and analytics modules; broader scale but limited Japan footprint.
  • Medidata Solutions (Dassault Systèmes): Clinical research data platform provider for pharma. Comparable as a pharma-research oriented data infrastructure vendor competing for similar sponsor budgets on the R&D side.

Direct peers

  • M3 (m3.com): Japanese healthcare platform operating MR-kun, MD-Voice, and drug marketing data businesses overlapping with MEI's pharma RWD and physician engagement services; targets overlapping pharmaceutical and hospital customers.
  • JMDC: Japan's leading RWD/healthcare data analytics company for pharma and academia. Provides claims data and EMR-derived datasets; competes head-to-head with MEI RWD for pharmaceutical R&D, HEOR, and academic research contracts.
  • Flatiron Health: Roche-owned oncology-focused real-world evidence and EHR data platform. Highly comparable for hospital-derived EMR data monetization to pharma research customers, narrower therapeutic focus.
  • TriNetX: Global real-world data network for clinical research and observational studies; comparable RWD-as-a-service model targeting pharma and academic users analogous to MEI RWD.

Regional players

  • DeNA (Healthcare / MYCODE): Japanese internet conglomerate with healthcare and consumer health data businesses. Operates in the same Japanese market with overlapping patient-facing health information and data analytics themes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

Medical Engineering Institute social profiles

Digital presence

Medical Engineering Institute compliance and trust

Trust signal

Compliance4 records

Medical Engineering Institute financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Medical Engineering Institute leadership team

Management profile

Number of profiles

Profiles8 records

Medical Engineering Institute funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Medical Engineering Institute M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medical Engineering Institute

What does Medical Engineering Institute do?

Medical Engineering Institute develops and sells the CLISTA! medical data warehouse (DWH) system that aggregates data from hospital electronic medical records, medical accounting, and departmental systems for search, statistical analysis, and alert notifications. It also provides MEI RWD (Real-World Data) services that supply anonymized/pseudonymized electronic medical record data to pharmaceutical companies and academic institutions, and operates the Two-In patient-facing mobile application (PHR) that connects patients with their medical institutions.

Is Medical Engineering Institute a public or private company?

Medical Engineering Institute is a private company. It is classified as corporate owned and is currently operating.

When was Medical Engineering Institute founded?

Medical Engineering Institute was founded in 2004. It employs 51 to 100 people.

Where is Medical Engineering Institute based?

Medical Engineering Institute is headquartered in Tsu, Japan, in the Asia region.

How does Medical Engineering Institute make money?

Four revenue lines are on record. CLISTA! Medical DWH System is the primary driver. The others are real-World Data (RWD) Services, ツーイン (Two-In) Patient App and hospital Management Consulting / Support Services.

Who are Medical Engineering Institute's main competitors?

Broad incumbents on record are Oracle Health (formerly Cerner), IQVIA Holdings, 3M Health Information Systems, Epic Systems and Medidata Solutions (Dassault Systèmes). Direct peers are M3 (m3.com), JMDC, Flatiron Health and TriNetX. DeNA (Healthcare / MYCODE) is listed as a regional player.

Does Medical Engineering Institute have an API?

No public API is recorded for Medical Engineering Institute.

What industry is Medical Engineering Institute in?

Medical Engineering Institute's product category is Healthcare Data Analytics Software. Its primary akta.pro industry code is HLACAIAJ, Real-World Data (RWD) Platforms & Clinical Data Curation, with a secondary code of HLACAIAI, FHIR/HL7 Data Repositories & Canonical Data Models. Its NAICS code is 541511 and its SIC code is 7370.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Prtimes医療用DWH「CLISTA!」、全国導入200施設を突破Medical Engineering Institute announced that its medical data warehouse CLISTA! has been installed in over 200 medical facilities nationwide. The company will showcase practical examples and live demonstrations at the International Modern Hospital Show 2026 in July.Monash UniversityAI platform aims to transform aged care by embedding research evidence into everyday practiceMonash University researchers are developing an AI-enabled platform called Evidencea to embed research evidence into aged care decision-making, supported by a Monash Institute of Medical Engineering (MIME) Invent Support grant. The platform integrates fragmented data from multiple aged care systems through an API-driven approach, enabling evidence-based risk prediction for quality indicators including falls, pressure injuries, hospitalisations and weight loss. The team is now testing the platform with residential and in-home care providers nationally while exploring commercialisation pathways for broader sector deployment.Monash UniversityAI platform aims to transform aged care by embedding research evidence into everyday practiceAn AI-enabled platform called Evidencea is being developed at Monash University with support from the Monash Institute of Medical Engineering (MIME) to embed research evidence directly into aged care decision-making. The platform integrates fragmented data from multiple aged care systems nationally and links it with quality research to help providers proactively identify and respond to risks including falls and pressure injuries under the new Aged Care Act. The team is now testing the platform with aged care partners and planning to expand to additional quality indicators while exploring potential commercialisation pathways.